Difference between revisions of "Scientific Articles on Psychedelics"

From DMT-Nexus Wiki
Jump to: navigation, search
(→‎Other)
(→‎Other)
 
(10 intermediate revisions by one user not shown)
Line 1: Line 1:
−
{{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}}
+
{{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}}<br />
−
 
+
−
 
+
 
==Ayahuasca==
 
==Ayahuasca==
 
{{FileReference
 
{{FileReference
Line 104: Line 102:
 
|
 
|
 
}}
 
}}
 +
  
 
==DMT==
 
==DMT==
Line 127: Line 126:
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
 
|[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]]
 
|[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]]
−
|
 
−
|0px
 
−
}}
 
−
{{FileReference
 
−
|[[Image:Page_white_acrobat.png]]
 
−
|[[Media:Excretion of DMT in Psychiatric Patients.pdf|Excretion of DMT in Psychiatric Patients]]
 
 
|
 
|
 
}}
 
}}
 +
  
 
==Ibogaine==
 
==Ibogaine==
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:fatalities after ibogaine use.pdf|Fatalities after ibogaine use]]
 
|
 
|
 
|0px
 
|0px
Line 145: Line 139:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:ibogaine and cocaine abuse.pdf|Ibogaine and cocaine abuse]]
 
|
 
|
 
|0px
 
|0px
Line 151: Line 145:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:ibogaine and facilitation of memory retrieval.pdf|Ibogaine and facilitation of memory retrieval]]
 
|
 
|
 
|0px
 
|0px
Line 157: Line 151:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Ibogaine mechanisms of anti addiction.pdf|Ibogaine mechanisms of anti addiction]]
 
|
 
|
 
|0px
 
|0px
Line 163: Line 157:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:ibogaine safety and efficacy.pdf|Ibogaine safety and efficacy]]
 
|
 
|
−
|0px
 
 
}}
 
}}
  
−
[{UP}PDF/Science/fatalities after ibogaine use.pdf|Fatalities after ibogaine use.pdf]
 
−
[{UP}PDF/Science/ibogaine and cocaine abuse.pdf|Ibogaine and cocaine abuse.pdf]
 
−
[{UP}PDF/Science/ibogaine and facilitation of memory retrieval.pdf|Ibogaine and facilitation of memory retrieval.pdf]
 
−
[{UP}PDF/Science/Ibogaine mechanisms of anti addiction.pdf|Ibogaine mechanisms of anti addiction.pdf]
 
−
[{UP}PDF/Science/ibogaine safety and efficacy.pdf|Ibogaine safety and efficacy.pdf]
 
  
 
==LSD==
 
==LSD==
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:long term effects of lsd.pdf|Long term effects of LSD]]
 
|
 
|
 
|0px
 
|0px
Line 183: Line 171:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:therapy with lsd.pdf|Therapy with LSD]]
 
|
 
|
 
}}
 
}}
  
−
[{UP}PDF/Science/long term effects of lsd.pdf|Long term effects of LSD.pdf]
 
−
[{UP}PDF/Science/therapy with lsd.pdf|Therapy with LSD.pdf]
 
  
 
==Peyote==
 
==Peyote==
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:A STUDY ON MESCALINE IN HUMAN SUBJECTS.pdf|A Study on mescaline in human subjects]]
 
|
 
|
 
|0px
 
|0px
Line 199: Line 185:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:peyote long term psychological cognitive effects.pdf|Peyote long term psychological cognitive effects]]
 
|
 
|
 
|0px
 
|0px
Line 205: Line 191:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:prehistoric peyote use.pdf|Prehistoric peyote use]]
 
|
 
|
 
}}
 
}}
−
[{UP}PDF/Science/A STUDY ON MESCALINE IN HUMAN SUBJECTS.pdf|A Study on mescaline in human subjects.pdf]
+
 
−
[{UP}PDF/Science/peyote long term psychological cognitive effects.pdf|Peyote long term psychological cognitive effects.pdf]
+
−
[{UP}PDF/Science/prehistoric peyote use.pdf|Prehistoric peyote use.pdf]
+
  
 
==Psilocybin==
 
==Psilocybin==
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:cluster headache lsd psilocybin.pdf|Cluster headache lsd psilocybin]]
 
|
 
|
 
|0px
 
|0px
Line 221: Line 205:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:effects of psilocybin on humans.pdf|Effects of psilocybin on humans]]
 
|
 
|
 
|0px
 
|0px
Line 227: Line 211:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:effects of psilocybin on perception of time.pdf|Effects of psilocybin on perception of time]]
 
|
 
|
 
|0px
 
|0px
Line 233: Line 217:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psilocybin and mystical experiences.pdf|Psilocybin and mystical experiences]]
 
|
 
|
 
|0px
 
|0px
Line 239: Line 223:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Psilocybin and OCD.pdf|Psilocybin and OCD]]
 
|
 
|
 
|0px
 
|0px
Line 245: Line 229:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psilocybin investigator brochure.pdf|Psilocybin investigator brochure]]
 
|
 
|
 
|0px
 
|0px
Line 251: Line 235:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psilocybin, attention and working memory.pdf|Psilocybin, attention and working memory]]
 
|
 
|
 
|0px
 
|0px
Line 257: Line 241:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psychedelic mushrooms in buddhist tradition.pdf|Psychedelic mushrooms in buddhist tradition]]
 
|
 
|
 
}}
 
}}
  
−
[{UP}PDF/Science/cluster headache lsd psilocybin.pdf|Cluster headache lsd psilocybin.pdf]
 
−
[{UP}PDF/Science/effects of psilocybin on humans.pdf|Effects of psilocybin on humans.pdf]
 
−
[{UP}PDF/Science/effects of psilocybin on perception of time.pdf|Effects of psilocybin on perception of time.pdf]
 
−
[{UP}PDF/Science/psilocybin and mystical experiences.pdf|Psilocybin and mystical experiences.pdf]
 
−
[{UP}PDF/Science/Psilocybin and OCD.pdf|Psilocybin and OCD.pdf]
 
−
[{UP}PDF/Science/psilocybin investigator brochure.pdf|Psilocybin investigator brochure.pdf]
 
−
[{UP}PDF/Science/psilocybin, attention and working memory.pdf|Psilocybin, attention and working memory.pdf]
 
−
[{UP}PDF/Science/psychedelic mushrooms in buddhist tradition.pdf|Psychedelic mushrooms in buddhist tradition.pdf]
 
  
 
==Salvia Divinorum==
 
==Salvia Divinorum==
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:salvia divinorum pattern of use.pdf|Salvia divinorum pattern of use]]
 
|
 
|
 
|0px
 
|0px
Line 279: Line 255:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Salv_A_PNAS.pdf|Salv_A_PNAS]]
 
|
 
|
 
}}
 
}}
−
[{UP}PDF/Science/salvia divinorum pattern of use.pdf|Salvia divinorum pattern of use.pdf]
+
 
−
[{UP}PDF/Science/Salv_A_PNAS.pdf|Salv_A_PNAS.pdf]
+
  
 
==Other==
 
==Other==
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Jf00077a037.pdf|Alkaloidal insect antifeedants from Virola calophylla]]
 +
|Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797
 +
|0px
 +
}}
 +
{{FileReference
 +
|[[Image:Page_white_acrobat.png]]
 +
|[[Media:bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen]]
 
|
 
|
 
|0px
 
|0px
Line 294: Line 275:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:entheogens and education potential.pdf|Entheogens and education potential]]
 
|
 
|
 
|0px
 
|0px
Line 300: Line 281:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:hallucinogens and redemption.pdf|Hallucinogens and redemption]]
 
|
 
|
 
|0px
 
|0px
Line 306: Line 287:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:HPPD - flashbacks.pdf|HPPD - flashbacks]]
 
|
 
|
 
|0px
 
|0px
Line 312: Line 293:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872]]
 
|
 
|
 
|0px
 
|0px
Line 318: Line 299:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC]]
 
|
 
|
 
|0px
 
|0px
 
}}
 
}}
−
 
−
[{UP}PDF/Science/bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen.pdf]
 
−
[{UP}PDF/Science/entheogens and education potential.pdf|Entheogens and education potential.pdf]
 
−
[{UP}PDF/Science/hallucinogens and redemption.pdf|Hallucinogens and redemption.pdf]
 
−
[{UP}PDF/Science/HPPD - flashbacks.pdf|HPPD - flashbacks.pdf]
 
−
[{UP}PDF/Science/JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872.pdf]
 
−
[{UP}PDF/Science/Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC.pdf]
 
−
 
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA]]
 
|
 
|
 
|0px
 
|0px
Line 338: Line 311:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Nichols - Hallucinogens.pdf|Nichols - Hallucinogens]]
 
|
 
|
 
|0px
 
|0px
Line 344: Line 317:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology]]
 
|
 
|
 
|0px
 
|0px
Line 350: Line 323:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology]]
 
|
 
|
 
|0px
 
|0px
Line 356: Line 329:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep]]
 
|
 
|
 
|0px
 
|0px
Line 362: Line 335:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psychedelic adverse effects.pdf|Psychedelic adverse effects]]
 
|
 
|
 
|0px
 
|0px
 
}}
 
}}
−
 
−
 
−
 
−
[{UP}PDF/Science/natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA.pdf]
 
−
[{UP}PDF/Science/Nichols - Hallucinogens.pdf|Nichols - Hallucinogens.pdf]
 
−
[{UP}PDF/Science/pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology.pdf]
 
−
[{UP}PDF/Science/pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology.pdf]
 
−
[{UP}PDF/Science/Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep.pdf]
 
−
[{UP}PDF/Science/psychedelic adverse effects.pdf|Psychedelic adverse effects.pdf]
 
−
 
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach]]
 
|
 
|
 
|0px
 
|0px
Line 384: Line 347:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens]]
 
|
 
|
 
|0px
 
|0px
Line 390: Line 353:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model]]
 
|
 
|
 
|0px
 
|0px
Line 396: Line 359:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting]]
 
|
 
|
 
|0px
 
|0px
Line 402: Line 365:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:serotonin and hallucinogens.pdf|Serotonin and hallucinogens]]
 
|
 
|
 
|0px
 
|0px
Line 408: Line 371:
 
{{FileReference
 
{{FileReference
 
|[[Image:Page_white_acrobat.png]]
 
|[[Image:Page_white_acrobat.png]]
−
|[[Media:placehere]]
+
|[[Media:study of Values of psychedelic users.pdf|Study of Values of psychedelic users]]
 
|
 
|
 
}}
 
}}
−
 
−
[{UP}PDF/Science/Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach.pdf]
 
−
[{UP}PDF/Science/Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens.pdf]
 
−
[{UP}PDF/Science/psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model.pdf]
 
−
[{UP}PDF/Science/reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting.pdf]
 
−
[{UP}PDF/Science/serotonin and hallucinogens.pdf|Serotonin and hallucinogens.pdf]
 
−
[{UP}PDF/Science/study of Values of psychedelic users.pdf|Study of Values of psychedelic users.pdf]
 
  
 
[[Category:Supplementary Reference]]
 
[[Category:Supplementary Reference]]

Latest revision as of 11:43, 24 October 2011

Error.png Note: This page is a work in progress -- its content throughout is not yet complete.

Ayahuasca

Page white acrobat.png Ayahuasca and SSRI Interactions Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369.
Page white acrobat.png Ayahuasca Adolescents ritual use Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144.
Page white acrobat.png ayahuasca first time psychological after effects Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30.
Page white acrobat.png Ayahuasca and human destiny McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234.
Page white acrobat.png Another Ayahuasca EEG study Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628.
Page white acrobat.png Ayahuasca in adolescence psychiatric evaluation
Page white acrobat.png ayahuasca in cross cultural perspective
Page white acrobat.png Ayahuasca neuroimaging
Page white acrobat.png Bringing Ayahuasca to clinical laboratory
Page white acrobat.png Effects of ayahuasca on panic and anxiety.pdf
Page white acrobat.png Globalization of ayahuasca
Page white acrobat.png Human pharmacology of ayahuasca
Page white acrobat.png Pharmacokinetics of hoasca in healthy humans
Page white acrobat.png Risk assessment of ritual ayahuasca use
Page white acrobat.png Thesis - Ayahuascapharmacology part1
Page white acrobat.png Thesis - ayahuascapharmacology part2
Page white acrobat.png Various alkaloid profiles in aya decoction


DMT

Page white acrobat.png DMT and BCarbolines in human plasma after dose
Page white acrobat.png DMT endogenous anxiolytic role
Page white acrobat.png DMT in psychiatric patients
Page white acrobat.png DMT psychopharmacology


Ibogaine

Page white acrobat.png Fatalities after ibogaine use
Page white acrobat.png Ibogaine and cocaine abuse
Page white acrobat.png Ibogaine and facilitation of memory retrieval
Page white acrobat.png Ibogaine mechanisms of anti addiction
Page white acrobat.png Ibogaine safety and efficacy


LSD

Page white acrobat.png Long term effects of LSD
Page white acrobat.png Therapy with LSD


Peyote

Page white acrobat.png A Study on mescaline in human subjects
Page white acrobat.png Peyote long term psychological cognitive effects
Page white acrobat.png Prehistoric peyote use


Psilocybin

Page white acrobat.png Cluster headache lsd psilocybin
Page white acrobat.png Effects of psilocybin on humans
Page white acrobat.png Effects of psilocybin on perception of time
Page white acrobat.png Psilocybin and mystical experiences
Page white acrobat.png Psilocybin and OCD
Page white acrobat.png Psilocybin investigator brochure
Page white acrobat.png Psilocybin, attention and working memory
Page white acrobat.png Psychedelic mushrooms in buddhist tradition


Salvia Divinorum

Page white acrobat.png Salvia divinorum pattern of use
Page white acrobat.png Salv_A_PNAS


Other

Page white acrobat.png Alkaloidal insect antifeedants from Virola calophylla Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797
Page white acrobat.png Bufo alvarius - a potent hallucinogen
Page white acrobat.png Entheogens and education potential
Page white acrobat.png Hallucinogens and redemption
Page white acrobat.png HPPD - flashbacks
Page white acrobat.png JPharmBioAn-41-3-872
Page white acrobat.png Mining_Recepterome_Review_JBC
Page white acrobat.png Natural hallucinogens growing in USA
Page white acrobat.png Nichols - Hallucinogens
Page white acrobat.png Pharmañopo - Yopo pharmacology
Page white acrobat.png Pharmepena - epena pharmacology
Page white acrobat.png Proposed Mechanism for Dreams and Sleep
Page white acrobat.png Psychedelic adverse effects
Page white acrobat.png Psychointegrators multidisciplinary approach
Page white acrobat.png Psychopharmacology of hallucinogens
Page white acrobat.png Psychosis and hallucinogens consciousness model
Page white acrobat.png Reducing drug problems with set and setting
Page white acrobat.png Serotonin and hallucinogens
Page white acrobat.png Study of Values of psychedelic users
Retrieved from "https://wiki.dmt-nexus.me/w/index.php?title=Scientific_Articles_on_Psychedelics&oldid=4652"